Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127782811 | 12778281 | 1 | I | 20160818 | 20160915 | 20160926 | 20160926 | EXP | FR-009507513-1609FRA008422 | MERCK | 48.87 | YR | F | Y | 0.00000 | 20160926 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127782811 | 12778281 | 1 | PS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 2 DF, TID | 12 | DF | Y | 62756 | 2 | DF | INTRAVENOUS INJECTION | TID | |||
| 127782811 | 12778281 | 2 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | 4 DF, TID | 108 | DF | Y | 0 | 4 | DF | TID | ||||
| 127782811 | 12778281 | 3 | C | SERESTA | OXAZEPAM | 1 | Oral | 50 MG, TID | 0 | 50 | MG | TID | |||||||
| 127782811 | 12778281 | 4 | C | TERCIAN | CYAMEMAZINE | 1 | Oral | 0.5 DF, QID | 0 | .5 | DF | SCORED TABLET | QID | ||||||
| 127782811 | 12778281 | 5 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 127782811 | 12778281 | 6 | C | RISPERDAL CONSTA | RISPERIDONE | 1 | Intramuscular | 1DF, QOW,50 MG/ 2 ML: POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION IN PRE-FILLE | D | 0 | 1 | DF | SUSPENSION FOR INJECTION | QOW | |||||
| 127782811 | 12778281 | 7 | C | RISPERDAL | RISPERIDONE | 1 | 1 DF, QD | D | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127782811 | 12778281 | 1 | Lung disorder |
| 127782811 | 12778281 | 2 | Pneumocystis jirovecii pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127782811 | 12778281 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127782811 | 12778281 | Hyperthermia | |
| 127782811 | 12778281 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127782811 | 12778281 | 1 | 20160817 | 20160818 | 0 | |
| 127782811 | 12778281 | 2 | 20160810 | 20160818 | 0 | |
| 127782811 | 12778281 | 6 | 20160819 | 0 | ||
| 127782811 | 12778281 | 7 | 201608 | 0 |